List of Tables
    Table 1. Human Cytomegalovirus Envelope Glycoprotein B CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Human Cytomegalovirus Envelope Glycoprotein B Market Trends
    Table 3. Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
    Table 4. Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
    Table 5. Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
    Table 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Human Cytomegalovirus Envelope Glycoprotein B Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Human Cytomegalovirus Envelope Glycoprotein B Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Human Cytomegalovirus Envelope Glycoprotein B Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Manufacturer, 2017-2022
    Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2021)
    Table 18. Top Players of Human Cytomegalovirus Envelope Glycoprotein B in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Type
    Table 20. Date of International Manufacturers Enter into Human Cytomegalovirus Envelope Glycoprotein B Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Human Cytomegalovirus Envelope Glycoprotein B Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Human Cytomegalovirus Envelope Glycoprotein B Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Astellas Pharma Inc. Corporation Information
    Table 43. Astellas Pharma Inc. Description and Business Overview
    Table 44. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product
    Table 46. Astellas Pharma Inc. Recent Development
    Table 47. Trellis Bioscience, Inc. Corporation Information
    Table 48. Trellis Bioscience, Inc. Description and Business Overview
    Table 49. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Trellis Bioscience, Inc. Product
    Table 51. Trellis Bioscience, Inc. Recent Development
    Table 52. Vakzine Projekt Management GmbH Corporation Information
    Table 53. Vakzine Projekt Management GmbH Description and Business Overview
    Table 54. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Vakzine Projekt Management GmbH Product
    Table 56. Vakzine Projekt Management GmbH Recent Development
    Table 57. VBI Vaccine Inc Corporation Information
    Table 58. VBI Vaccine Inc Description and Business Overview
    Table 59. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. VBI Vaccine Inc Product
    Table 61. VBI Vaccine Inc Recent Development
    Table 62. Vical Incorporated Corporation Information
    Table 63. Vical Incorporated Description and Business Overview
    Table 64. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Vical Incorporated Product
    Table 66. Vical Incorporated Recent Development
    Table 67. Key Raw Materials Lists
    Table 68. Raw Materials Key Suppliers Lists
    Table 69. Human Cytomegalovirus Envelope Glycoprotein B Customers List
    Table 70. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Cytomegalovirus Envelope Glycoprotein B Product Picture
    Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size 2017-2028 (US$ Million)
    Figure 4. Global Human Cytomegalovirus Envelope Glycoprotein B Sales 2017-2028 (K Pcs)
    Figure 5. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Human Cytomegalovirus Envelope Glycoprotein B Market Size 2017-2028 (US$ Million)
    Figure 7. United States Human Cytomegalovirus Envelope Glycoprotein B Sales 2017-2028 (K Pcs)
    Figure 8. United States Human Cytomegalovirus Envelope Glycoprotein B Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Human Cytomegalovirus Envelope Glycoprotein B Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered
    Figure 11. Product Picture of CSJ-148
    Figure 12. Product Picture of CyMVectin
    Figure 13. Product Picture of TRL-345
    Figure 14. Product Picture of PPCM
    Figure 15. Product Picture of Cytomegalovirus Vaccine
    Figure 16. Product Picture of Others
    Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type in 2022 & 2028
    Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2028) & (K Pcs)
    Figure 21. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2017-2028) & (USD/Pcs)
    Figure 23. United States Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type in 2022 & 2028
    Figure 24. United States Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2028) & (K Pcs)
    Figure 27. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2017-2028) & (USD/Pcs)
    Figure 29. Product Picture of Infectious Disease
    Figure 30. Product Picture of Oncology
    Figure 31. Product Picture of Women's Health
    Figure 32. Product Picture of Others
    Figure 33. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2022 & 2028
    Figure 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2028) & (K Pcs)
    Figure 37. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2017-2028) & (USD/Pcs)
    Figure 39. United States Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2022 & 2028
    Figure 40. United States Human Cytomegalovirus Envelope Glycoprotein B Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2028) & (K Pcs)
    Figure 43. United States Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2017-2028) & (USD/Pcs)
    Figure 45. North America Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. North America Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 57. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 74. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Human Cytomegalovirus Envelope Glycoprotein B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Human Cytomegalovirus Envelope Glycoprotein B Value Chain
    Figure 79. Human Cytomegalovirus Envelope Glycoprotein B Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed